Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity
- Noel M. Caplice
- , Cheryl S. Mueske
- , Laurel S. Kleppe
- , Robert D. Simari
- Mayo Clinic Rochester, MN
Research output: Contribution to journal › Article › peer-review